Journey Medical Corporation
DERM
$5.01
$0.010.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.31% | 16.38% | 1.04% | 0.84% | -17.28% |
| Total Other Revenue | -98.70% | -- | -- | -- | -- |
| Total Revenue | 18.05% | 20.52% | 1.04% | 0.84% | -10.73% |
| Cost of Revenue | 16.24% | 28.72% | -13.76% | -20.19% | 108.19% |
| Gross Profit | 19.00% | 16.91% | 10.32% | 18.80% | -31.28% |
| SG&A Expenses | -1.96% | 5.77% | 15.05% | 25.52% | 2.23% |
| Depreciation & Amortization | 8.56% | 30.71% | 30.71% | 30.84% | -73.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.11% | 9.34% | 0.58% | -28.79% | -34.42% |
| Operating Income | -119.83% | 47.17% | 1.74% | 67.06% | 206.18% |
| Income Before Tax | -178.82% | 3.14% | -11.16% | 60.99% | 178.43% |
| Income Tax Expenses | -100.00% | -- | -- | -- | -51.59% |
| Earnings from Continuing Operations | -181.99% | 3.14% | -12.94% | 60.99% | 170.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -181.99% | 3.14% | -12.94% | 60.99% | 170.98% |
| EBIT | -119.83% | 47.17% | 1.74% | 67.06% | 206.18% |
| EBITDA | -80.65% | 77.64% | 14.20% | 75.65% | 349.42% |
| EPS Basic | -164.43% | 20.27% | 3.03% | 65.92% | 162.30% |
| Normalized Basic EPS | -162.07% | 45.79% | 4.57% | 65.91% | 168.84% |
| EPS Diluted | -164.43% | 20.27% | 3.03% | 65.92% | 159.95% |
| Normalized Diluted EPS | -162.07% | 45.79% | 4.57% | 65.91% | 168.84% |
| Average Basic Shares Outstanding | 27.18% | 21.53% | 16.49% | 14.44% | 14.00% |
| Average Diluted Shares Outstanding | 27.18% | 21.53% | 16.49% | 14.44% | 14.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |